Suspensory trigemino-sympathetic novocaine blockade
- Authors: Zhakov M.P.1
-
Affiliations:
- Ivanovo Medical Institute
- Issue: Vol 41, No 5 (1960)
- Pages: 66-66
- Section: Articles
- URL: https://ogarev-online.ru/kazanmedj/article/view/80966
- DOI: https://doi.org/10.17816/kazmj80966
- ID: 80966
Cite item
Full Text
Abstract
The suspensory trigemino-sympathetic novocaine blockade was developed by the author and put into practice in 1953. Its therapeutic value is based on the effect of: 0.25% novocaine solution on the maxillary and mandibular nerves (the second and third branches of the trigeminal nerve) with their branches and other nerve formations located in the sublingual and wing palatine fossa.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
M. P. Zhakov
Ivanovo Medical Institute
Author for correspondence.
Email: info@eco-vector.com
professor, Maxillofacial Department, hospital surgical clinic
Russian Federation, IvanovoReferences
Supplementary files
